The Pharma Legal Handbook: Hungary

Hungary is one of Central Europe's most important pharmaceutical markets, with a regulatory framework administered by the National Institute of Pharmacy and Nutrition (OGYEI). Hungary's reimbursement system is administered by the National Health Insurance Fund Administration (NEAK) and involves a well-defined process for listing and pricing decisions that requires specific local expertise.

Hungary is a significant reference country for pricing in the CEE region, and the prices achieved through NEAK negotiations have implications for other markets. The country also has specific rules around pharmacy-level substitution, generic prescribing, and the management of biosimilar uptake that operational teams need to understand.

The Pharma Legal Handbook: Hungary provides comprehensive guidance on pharmaceutical regulation in Hungary, covering OGYEI product authorisation, NEAK reimbursement pathways, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, parallel imports, and intellectual property protection.